WELL Health Technologies Balance Sheet Health
Financial Health criteria checks 2/6
WELL Health Technologies has a total shareholder equity of CA$985.4M and total debt of CA$533.7M, which brings its debt-to-equity ratio to 54.2%. Its total assets and total liabilities are CA$2.0B and CA$1.0B respectively. WELL Health Technologies's EBIT is CA$21.9M making its interest coverage ratio 0.5. It has cash and short-term investments of CA$98.9M.
Key information
54.16%
Debt to equity ratio
CA$533.69m
Debt
| Interest coverage ratio | 0.5x |
| Cash | CA$98.89m |
| Equity | CA$985.45m |
| Total liabilities | CA$1.03b |
| Total assets | CA$2.02b |
Recent financial health updates
These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well
Dec 31
Is WELL Health Technologies (TSE:WELL) A Risky Investment?
Sep 09WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Mar 21WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Oct 30We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt
Jul 17WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Apr 18Recent updates
WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 16Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)
Apr 23Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts
Apr 22WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%
Apr 01Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?
Mar 29
AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline
Market consolidation and clinic efficiency initiatives could significantly enhance WELL Health's revenue growth and net margins.These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well
Dec 31A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb
Nov 29When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?
Nov 11Is WELL Health Technologies (TSE:WELL) A Risky Investment?
Sep 09Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher
Jul 05WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price
Jun 11WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem
May 21WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Mar 21Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?
Feb 29The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)
Jan 18WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Oct 30We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt
Jul 17WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Apr 18Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?
Jan 13Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?
Nov 11Financial Position Analysis
Short Term Liabilities: WELL's short term assets (CA$358.6M) do not cover its short term liabilities (CA$386.2M).
Long Term Liabilities: WELL's short term assets (CA$358.6M) do not cover its long term liabilities (CA$647.4M).
Debt to Equity History and Analysis
Debt Level: WELL's net debt to equity ratio (44.1%) is considered high.
Reducing Debt: WELL's debt to equity ratio has increased from 21.5% to 54.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable WELL has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: WELL is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 31.9% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/28 20:25 |
| End of Day Share Price | 2025/08/27 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
WELL Health Technologies Corp. is covered by 15 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gabriel Leung | Beacon Securities Limited |
| Douglas Taylor | Canaccord Genuity |
| Scott Fletcher | CIBC Capital Markets |